Your browser doesn't support javascript.
loading
Changing the treatment paradigm for Parkinson's disease psychosis with pimavanserin.
Lyons, Kelly E; Pahwa, Rajesh; Hermanowicz, Neal; Davis, Thomas; Pagan, Fernando; Isaacson, Stuart.
Affiliation
  • Lyons KE; a Department of Neurology , University of Kansas Medical Center , Kansas City , KS , USA.
  • Pahwa R; a Department of Neurology , University of Kansas Medical Center , Kansas City , KS , USA.
  • Hermanowicz N; b Department of Neurology , University of California Irvine , Irvine , CA , USA.
  • Davis T; c Department of Neurology , Vanderbilt University Medical Center , Nashville , TN , USA.
  • Pagan F; d Department of Neurology , Georgetown University Medical Center , Washington , DC , USA.
  • Isaacson S; e Parkinson's Disease and Movement Disorders Center of Boca Raton , Boca Raton , FL , USA.
Expert Rev Clin Pharmacol ; 12(7): 681-691, 2019 Jul.
Article in En | MEDLINE | ID: mdl-31159608
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Piperidines / Psychotic Disorders / Urea Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Expert Rev Clin Pharmacol Year: 2019 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Piperidines / Psychotic Disorders / Urea Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Expert Rev Clin Pharmacol Year: 2019 Document type: Article Affiliation country: Estados Unidos